Literature DB >> 24989291

[Effects of rapamycin on biological characteristics of bone marrow mesenchymal stem cells from patients with aplastic anemia].

Xin Wang1, Feng-Xia Ma1, Shi-Hong Lu1, Ying Chi1, Fang Chen1, Xue Li1, Juan-Juan Li1, Wen-Jing Du1, Ying Feng1, Jun-Jie Cui1, Bao-Quan Song1, Zhong-Chao Han2.   

Abstract

This study was aimed to investigate the effects of rapamycin on biological function and autophagy of bone marrow mesenchymal stem cells (BM-MSC) from patients with aplastic anemia so as to provide experimental basis for the clinical treatment of aplastic anemia (AA) with rapamycin. BM-MSC were treated with different concentrations of rapamycin (0, 10, 50, 100 nmol/L) for 48 h, the expression of LC3B protein was detected by Western blot to observe the effect of rapamycin on cell autophagy; cell apoptosis and cell cycles were detected by flow cytometry; the proliferation of BM-MSC of AA patients was measured by cell counting kit-8; the adipogenic differentiation of BM-MSC were tested by oil red O staining after adipogenic induction for 2 weeks; the adipogenic related genes (LPL, CFD, PPARγ) were detected by real-time PCR. The results showed that the proliferation and adipogenesis of BM-MSC of AA patients were inhibited by rapamycin. Moreover, the autophagy and apoptosis of BM-MSC were increased by rapamycin in a dose-dependent way.Rapamycin arrested the BM-MSC in G0/G1 phase and prevented them into S phase (P < 0.05). It is concluded that rapamycin plays an critical role in inhibiting cell proliferation, cell cycles, and adipogenesis, these effects may be related with the autophagy activation and mTOR inhibition resulting from rapamycin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24989291     DOI: 10.7534/j.issn.1009-2137.2014.03.035

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  miR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2/PPARγ in aplastic anemia children and benzene-induced aplastic anemia mouse model.

Authors:  Huanhuan Li; Xueju Xu; Dao Wang; Li Zeng; Bai Li; Yuan Zhang; Shufang Su; Linlin Wei; Hongliang You; Yingqi Fang; Yingchao Wang; Yufeng Liu
Journal:  Cell Cycle       Date:  2020-08-25       Impact factor: 4.534

2.  Novel insights into a treatment for aplastic anemia based on the advanced proliferation of bone marrow‑derived mesenchymal stem cells induced by fibroblast growth factor 1.

Authors:  Shayi Jiang; Min Xia; Jingwei Yang; Jingbo Shao; Xuelian Liao; Jiashi Zhu; Hui Jiang
Journal:  Mol Med Rep       Date:  2015-10-09       Impact factor: 2.952

Review 3.  The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside.

Authors:  Yimei Feng; Xiaoli Chen; Kaniel Cassady; Zhongmin Zou; Shijie Yang; Zheng Wang; Xi Zhang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.